LMU researchers have shown that a particular type of immune cell acts more flexibly than previously thought—with the ...

In addition to patrolling the body for foreign invaders, the immune system also hunts down and destroys cells that have ...

Immorta Bio Inc., a leader in longevity-focused biotechnologies, announced today acceptance of its poster presentation at the upcoming Society for Immunotherapy of Cancer (SITC) Spring Scientific, ...

Discover how leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.

Discover a study that describes a host-intrinsic mechanism responsible for the failure of PD-L1 blockade in ovarian cancer.

Scientists have discovered a novel subset of cancer ... and Immunotherapy Program and Tumor Microenvironment Center at UPMC Hillman. "By better understanding different types of B cells and their ...

No writing assistance was utilized in the production of this manuscript. Plasmacytoid dendritic cells (pDCs) are specialized APCs. Compared with other APCs, pDCs express a high level of TLR9 and ...

Developing low side-effect pyroptosis and ferroptosis inducers for cancer therapy, especially dual function inducers, is a challenging task. Toward this goal, Li et al. design a multifunctional ...

Metformin is widely used to manage type 2 diabetes, but new research suggests it may also help the immune system fight cancer ...

Photoimmunotherapy is an innovative cancer treatment that combines phototherapy with immunotherapy to selectively target and destroy cancer cells. In ...